Santen Pharmaceutical Co., Ltd. (SNPHY)
10.55
-0.57
(-5.13%)
USD |
OTCM |
Oct 02, 16:00
Santen Pharmaceutical Profit Margin (Quarterly) : 10.44% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.44% |
| March 31, 2026 | 19.24% |
| December 31, 2025 | 11.17% |
| September 30, 2025 | 11.56% |
| June 30, 2025 | 8.53% |
| March 31, 2025 | 11.00% |
| December 31, 2024 | 11.32% |
| September 30, 2024 | 11.30% |
| June 30, 2024 | 14.19% |
| March 31, 2024 | 0.16% |
| December 31, 2023 | 9.48% |
| September 30, 2023 | 12.07% |
| June 30, 2023 | 14.38% |
| March 31, 2023 | 1.39% |
| December 31, 2022 | 8.36% |
| September 30, 2022 | -45.30% |
| June 30, 2022 | 10.21% |
| March 31, 2022 | 11.22% |
| December 31, 2021 | 7.52% |
| September 30, 2021 | 10.86% |
| June 30, 2021 | 11.33% |
| March 31, 2021 | -17.24% |
| December 31, 2020 | 11.52% |
| September 30, 2020 | 12.35% |
| June 30, 2020 | 10.64% |
| Date | Value |
|---|---|
| March 31, 2020 | 2.42% |
| December 31, 2019 | 11.25% |
| September 30, 2019 | 11.30% |
| June 30, 2019 | 10.81% |
| March 31, 2019 | 14.10% |
| December 31, 2018 | 15.27% |
| September 30, 2018 | 13.01% |
| June 30, 2018 | 12.13% |
| March 31, 2018 | 14.04% |
| December 31, 2017 | 20.93% |
| September 30, 2017 | 11.37% |
| June 30, 2017 | 15.93% |
| March 31, 2017 | 9.42% |
| December 31, 2016 | 8.82% |
| September 30, 2016 | 10.84% |
| June 30, 2016 | 14.64% |
| March 31, 2016 | 7.56% |
| December 31, 2015 | 12.14% |
| September 30, 2015 | 72.38% |
| June 30, 2015 | 15.72% |
| March 31, 2015 | 14.17% |
| December 31, 2014 | 16.72% |
| September 30, 2014 | 14.89% |
| June 30, 2014 | 12.07% |
| March 31, 2014 | 4.36% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Eisai Co., Ltd. | 8.17% |
| Chugai Pharmaceutical Co., Ltd. | 34.06% |
| Ono Pharmaceutical Co., Ltd. | 20.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.52% |
| Return on Assets | 9.49% |
| Return on Invested Capital | 12.06% |
| Gross Profit Margin (Quarterly) | 54.66% |
| Operating Margin (Quarterly) | 11.69% |
| Return on Net Operating Assets | 13.86% |